These drugs can be characterized by a different color or flavor than that of the original drug but their quality, performance, intended use, strength, dosage form and route of administration remain the same.
In addition to this, the high costs associated with a full-length cancer treatment have led a majority of the patients to opt for these drugs as they are much more cost-effective as compared to their brand-name counterparts.
They are continually engaging in research and development activities to reduce healthcare expenses related to cancer treatment, thus making the healthcare facility accessible and affordable for all.